- Phare
- Validé par KD/KO
Anticorps Recombinant de lapin anti-HER2/ErbB2,p185-Specific
HER2/ErbB2,p185-Specific Recombinant Antibody for WB, IHC, IF/ICC, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, souris
Applications
WB, IHC, IF/ICC, ELISA
Conjugaison
Non conjugué
CloneNo.
240802C2
N° de cat : 84046-1-PBS
Synonymes
Galerie de données de validation
Informations sur le produit
84046-1-PBS cible HER2/ErbB2,p185-Specific dans les applications de WB, IHC, IF/ICC, ELISA et montre une réactivité avec des échantillons Humain, souris
Réactivité | Humain, souris |
Hôte / Isotype | Lapin / IgG |
Clonalité | Recombinant |
Type | Anticorps |
Immunogène | Peptide |
Nom complet | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
Masse moléculaire calculée | 138 kDa |
Poids moléculaire observé | 185 kDa |
Numéro d’acquisition GenBank | BC167147 |
Symbole du gène | HER2/ErbB2 |
Identification du gène (NCBI) | 2064 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Protein A purfication |
Tampon de stockage | PBS only |
Conditions de stockage | Store at -80°C. 20ul contiennent 0,1% de BSA. |
Informations générales
HER2, also known as ErbB2 and Neu, is a 185-kDa transmembrane glycoprotein member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. It has no ligand-binding domain and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signaling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Amplification and overexpression of HER2 have been reported in numerous cancers, including breast and ovarian tumors. HER2 is a therapeutic target for the treatment of breast cancer and other carcinomas.